Literature DB >> 28096411

Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles.

Qiang Ding1, Brigitte Heller1, Juan M V Capuccino2, Bokai Song1, Ila Nimgaonkar1, Gabriela Hrebikova1, Jorge E Contreras2, Alexander Ploss3.   

Abstract

Hepatitis E virus (HEV) is the leading cause of enterically transmitted viral hepatitis globally. Of HEV's three ORFs, the function of ORF3 has remained elusive. Here, we demonstrate that via homophilic interactions ORF3 forms multimeric complexes associated with intracellular endoplasmic reticulum (ER)-derived membranes. HEV ORF3 shares several structural features with class I viroporins, and the function of HEV ORF3 can be maintained by replacing it with the well-characterized viroporin influenza A virus (IAV) matrix-2 protein. ORF3's ion channel function is further evidenced by its ability to mediate ionic currents when expressed in Xenopus laevis oocytes. Furthermore, we identified several positions in ORF3 critical for its formation of multimeric complexes, ion channel activity, and, ultimately, release of infectious particles. Collectively, our data demonstrate a previously undescribed function of HEV ORF3 as a viroporin, which may serve as an attractive target in developing direct-acting antivirals.

Entities:  

Keywords:  drug development; hepatitis E; hepatitis E virus; virion release; viroporin

Mesh:

Substances:

Year:  2017        PMID: 28096411      PMCID: PMC5293053          DOI: 10.1073/pnas.1614955114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.

Authors:  Suzanne U Emerson; Hanh Nguyen; Udana Torian; Robert H Purcell
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

2.  Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release.

Authors:  Wei Lu; Bo-Jian Zheng; Ke Xu; Wolfgang Schwarz; Lanying Du; Charlotte K L Wong; Jiadong Chen; Shuming Duan; Vincent Deubel; Bing Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

3.  The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton.

Authors:  M Zafrullah; M H Ozdener; S K Panda; S Jameel
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Brief communication: case reports of ribavirin treatment for chronic hepatitis E.

Authors:  Vincent Mallet; Elisabeth Nicand; Philippe Sultanik; Catherine Chakvetadze; Sophie Tessé; Eric Thervet; Luc Mouthon; Philippe Sogni; Stanislas Pol
Journal:  Ann Intern Med       Date:  2010-06-14       Impact factor: 25.391

5.  Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity.

Authors:  Yannick Debing; Christophe Ramière; Kai Dallmeier; Géraldine Piorkowski; Mary-Anne Trabaud; Fanny Lebossé; Caroline Scholtès; Magali Roche; Catherine Legras-Lachuer; Xavier de Lamballerie; Patrice André; Johan Neyts
Journal:  J Hepatol       Date:  2016-05-09       Impact factor: 25.083

6.  Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.

Authors:  Nassim Kamar; Lionel Rostaing; Florence Abravanel; Cyril Garrouste; Sebastien Lhomme; Laure Esposito; Grégoire Basse; Olivier Cointault; David Ribes; Marie Béatrice Nogier; Laurent Alric; Jean Marie Peron; Jacques Izopet
Journal:  Gastroenterology       Date:  2010-08-11       Impact factor: 22.682

7.  The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly.

Authors:  Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Takeshi Noda; Maki Kiso; Junko Maeda; Shinji Watanabe; Yukiko Muramoto; Ken Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

8.  A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells.

Authors:  Shigeo Nagashima; Masaharu Takahashi; Toshinori Tanaka; Kentaro Yamada; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Gen Virol       Date:  2010-11-10       Impact factor: 3.891

9.  Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication.

Authors:  Lauren Wilson; Peter Gage; Gary Ewart
Journal:  Virology       Date:  2006-07-03       Impact factor: 3.616

10.  The molecular basis of the specific anti-influenza action of amantadine.

Authors:  A J Hay; A J Wolstenholme; J J Skehel; M H Smith
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

View more
  75 in total

1.  Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.

Authors:  Dianjun Cao; Qian M Cao; Sakthivel Subramaniam; Danielle M Yugo; C Lynn Heffron; Adam J Rogers; Scott P Kenney; Debin Tian; Shannon R Matzinger; Christopher Overend; Nicholas Catanzaro; Tanya LeRoith; Heng Wang; Pablo Piñeyro; Nicole Lindstrom; Sherrie Clark-Deener; Lijuan Yuan; Xiang-Jin Meng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

2.  Antiviral Candidates for Treating Hepatitis E Virus Infection.

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Subhash G Vasudevan; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

3.  Potent Inhibition of Hepatitis E Virus Release by a Cyclic Peptide Inhibitor of the Interaction between Viral Open Reading Frame 3 Protein and Host Tumor Susceptibility Gene 101.

Authors:  Saumya Anang; Nidhi Kaushik; Smita Hingane; Anita Kumari; Jyoti Gupta; Shailendra Asthana; Baibaswata Nayak; C T Ranjith-Kumar; Milan Surjit
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

Review 4.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

Review 5.  Stem Cell-Derived Culture Models of Hepatitis E Virus Infection.

Authors:  Viet Loan Dao Thi; Xianfang Wu; Charles M Rice
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

6.  Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.

Authors:  Nicolas Capelli; Olivier Marion; Martine Dubois; Sophie Allart; Justine Bertrand-Michel; Sébastien Lhomme; Florence Abravanel; Jacques Izopet; Sabine Chapuy-Regaud
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

7.  Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway.

Authors:  Shigeo Nagashima; Masaharu Takahashi; Tominari Kobayashi; Tsutomu Nishizawa; Takashi Nishiyama; Putu Prathiwi Primadharsini; Hiroaki Okamoto
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

Review 8.  Hepatitis E Virus Genome Structure and Replication Strategy.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

9.  Hepatitis E Virus Genotype 3 Genomes from RNA-Positive but Serologically Negative Plasma Donors Have CUG as the Start Codon for ORF3.

Authors:  Heléne Norder; Cristina Galli; Ellen Magnil; Per Sikora; Elisabet Ekvärn; Kristina Nyström; Lars O Magnius
Journal:  Intervirology       Date:  2018-10-02       Impact factor: 1.763

10.  Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target.

Authors:  Changbo Qu; Shaoshi Zhang; Wenshi Wang; Meng Li; Yijin Wang; Marieke van der Heijde-Mulder; Ehsan Shokrollahi; Mohamad S Hakim; Nicolaas J H Raat; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  FASEB J       Date:  2018-08-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.